Ajooni Biotech Limited (AJOONI) - Total Assets
Based on the latest financial reports, Ajooni Biotech Limited (AJOONI) holds total assets worth Rs1.20 Billion INR (≈ $13.02 Million USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Ajooni Biotech Limited (AJOONI) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Ajooni Biotech Limited - Total Assets Trend (2013–2026)
This chart illustrates how Ajooni Biotech Limited's total assets have evolved over time, based on quarterly financial data. See Ajooni Biotech Limited shareholders equity for net asset value and shareholders' equity analysis.
Ajooni Biotech Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Ajooni Biotech Limited's total assets of Rs1.20 Billion consist of 61.9% current assets and 38.1% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 0.4% |
| Accounts Receivable | Rs319.83 Million | 26.6% |
| Inventory | Rs394.55 Million | 32.8% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs3.60 Million | 0.3% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2013–2026)
This chart illustrates how Ajooni Biotech Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Ajooni Biotech Limited (AJOONI) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ajooni Biotech Limited's current assets represent 61.9% of total assets in 2026, a decrease from 100.0% in 2013.
- Cash Position: Cash and equivalents constituted 0.4% of total assets in 2026, down from 100.0% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is inventory at 32.8% of total assets.
Ajooni Biotech Limited Competitors by Total Assets
Key competitors of Ajooni Biotech Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Saputo Inc
TO:SAP
|
Canada | CA$13.61 Billion |
|
Orkla ASA
OL:ORK
|
Norway | Nkr88.70 Billion |
|
Tingyi (Cayman Islands) Holding Corp
F:TYG
|
Germany | €54.94 Billion |
|
Maple Leaf Foods Inc.
TO:MFI
|
Canada | CA$4.45 Billion |
|
Grupo Herdez S.A.B. de C.V
MX:HERDEZ
|
Mexico | MX$35.95 Billion |
|
Scandi Standard publ AB
ST:SCST
|
Sweden | Skr7.65 Billion |
|
Kri-Kri Milk Industry S.A
AT:KRI
|
Greece | €219.80 Million |
|
Namchow Food Group (Shanghai) Co. Ltd.
SHG:605339
|
China | CN¥4.18 Billion |
Ajooni Biotech Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.72 | 12.86 | 2.04 |
| Quick Ratio | 1.28 | 7.89 | 1.57 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs471.29 Million | Rs571.83 Million | Rs116.84 Million |
Ajooni Biotech Limited - Advanced Valuation Insights
This section examines the relationship between Ajooni Biotech Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.70 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 26.6% |
| Total Assets | Rs1.20 Billion |
| Market Capitalization | $7.43 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ajooni Biotech Limited's assets below their book value (0.01x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ajooni Biotech Limited's assets grew by 26.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ajooni Biotech Limited (2013–2026)
The table below shows the annual total assets of Ajooni Biotech Limited from 2013 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs1.20 Billion ≈ $13.02 Million |
+26.63% |
| 2025-03-31 | Rs950.51 Million ≈ $10.28 Million |
+100.02% |
| 2024-03-31 | Rs475.20 Million ≈ $5.14 Million |
-19.09% |
| 2023-03-31 | Rs587.31 Million ≈ $6.35 Million |
+102.40% |
| 2022-03-31 | Rs290.18 Million ≈ $3.14 Million |
+3.54% |
| 2021-03-31 | Rs280.26 Million ≈ $3.03 Million |
+21.50% |
| 2020-03-31 | Rs230.67 Million ≈ $2.49 Million |
+26.40% |
| 2019-03-31 | Rs182.50 Million ≈ $1.97 Million |
-5.51% |
| 2018-03-31 | Rs193.14 Million ≈ $2.09 Million |
+50.23% |
| 2017-03-31 | Rs128.56 Million ≈ $1.39 Million |
+429.44% |
| 2016-03-31 | Rs24.28 Million ≈ $262.60K |
+50.51% |
| 2015-03-31 | Rs16.13 Million ≈ $174.47K |
+223.57% |
| 2014-03-31 | Rs4.99 Million ≈ $53.92K |
+6637.84% |
| 2013-03-31 | Rs74.00K ≈ $800.28 |
-- |
About Ajooni Biotech Limited
Ajooni Biotech Limited manufactures and sells cattle feed in India. Its portfolio includes cattle feed chips, camel and pig feed, cotton oil cakes, mustard oil cakes, and feed supplements. The company was incorporated in 2010 and is based in Mohali, India.